Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways

References

• Suresh R, Kupfer Y, Tessler S. Acute respiratory distress syndrome. N Engl J Med. 2000;343(9):660–661. doi:10.1056/NEJM200008313430914.
   PubMed Web of Science ®Google Scholar
• Mirakaj V, Thix CA, Laucher S, et al. Netrin-1 dampens pulmonary inflammation during acute lung injury. Am J Respir Crit Care Med. 2010;181(8):815–824. doi:10.1164/rccm.200905-0717OC.
   PubMed Web of Science ®Google Scholar
• Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–1693. doi:10.1056/NEJMoa050333.
   PubMed Web of Science ®Google Scholar
• Andonegui G, Bonder CS, Green F, et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest. 2003;111(7):1011–1020. doi:10.1172/JCI16510.
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295(3):L379–L399. doi:10.1152/ajplung.00010.2008.
   PubMed Web of Science ®Google Scholar
• Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–1308. doi:10.1056/NEJM200005043421801.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2003;167(7):1027–1035. doi:10.1164/rccm.200208-966WS.
   PubMed Web of Science ®Google Scholar
• Ganter MT, Roux J, Miyazawa B, et al. Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms. Circ Res. 2008;102(7):804–812. doi:10.1161/CIRCRESAHA.107.161067.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhou J, Ju Y, et al. Effects of two saponins extracted from the Polygonatum zanlanscianense Pamp on the human leukemia (HL-60) cells. Biol Pharm Bull. 2001;24(2):159–162. doi:10.1248/bpb.24.159.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang Y, Wu C, et al. Dioscin's antiviral effect in vitro. Virus Res. 2013;172(1-2):9–14. doi:10.1016/j.virusres.2012.12.001.
   PubMed Web of Science ®Google Scholar
• Cho J, Choi H, Lee J, et al. The antifungal activity and membrane-disruptive action of dioscin extracted from Dioscorea nipponica. Biochim Biophys Acta. 2013;1828(3):1153–1158. doi:10.1016/j.bbamem.2012.12.010.
   PubMed Web of Science ®Google Scholar
• Ma T, Wang RP, Zou X. Dioscin inhibits gastric tumor growth through regulating the expression level of lncRNA HOTAIR. BMC Complement Altern Med. 2016;16(1):383. doi:10.1186/s12906-016-1360-1.
   PubMed Web of Science ®Google Scholar
• Zhang G, Zeng X, Zhang R, et al. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3. Phytomedicine. 2016;23(12):1329–1336. doi:10.1016/j.phymed.2016.07.003.
   PubMed Web of Science ®Google Scholar
• Lv L, Zheng L, Dong D, et al. Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: a potential new drug for treatment of glioblastoma multiforme. Food Chem Toxicol. 2013;59:657–669. doi:10.1016/j.fct.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Chen H, Xu L, Yin L, et al. iTRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells. Proteomics. 2014;14(1):51–73. doi:10.1002/pmic.201300101.
   PubMed Web of Science ®Google Scholar
• Tong Q, Qing Y, Wu Y, et al. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways. Toxicol Appl Pharmacol. 2014;281(2):166–173. doi:10.1016/j.taap.2014.07.026.
   PubMed Web of Science ®Google Scholar
• Su J, Wei Y, Liu M, et al. Anti-hyperuricemic and nephroprotective effects of Rhizoma Dioscoreae septemlobae extracts and its main component dioscin via regulation of mOAT1, mURAT1 and mOCT2 in hypertensive mice. Arch Pharm Res. 2014;37(10):1336–1344. doi:10.1007/s12272-014-0413-6.
   PubMed Web of Science ®Google Scholar
• Liu M, Xu L, Yin L, et al. Corrigendum: Potent effects of dioscin against obesity in mice. Sci Rep. 2015;5(1):12183.doi:10.1038/srep12183.
   PubMed Web of Science ®Google Scholar
• Tao X, Sun X, Yin L, et al. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition. Free Radic Biol Med. 2015;84:103–115. doi:10.1016/j.freeradbiomed.2015.03.003.
   PubMed Web of Science ®Google Scholar
• Hu Y, Tao X, Han X, et al. Dioscin attenuates gastric ischemia/reperfusion injury through the down-regulation of PKC/ERK1/2 signaling via PKCalpha and PKCbeta2 inhibition. Chem Biol Interact. 2016;258:234–244. doi:10.1016/j.cbi.2016.09.014.
   PubMed Web of Science ®Google Scholar
• Tao X, Wan X, Xu Y, et al. Dioscin attenuates hepatic ischemia-reperfusion injury in rats through inhibition of oxidative-nitrative stress, inflammation and apoptosis. Transplantation. 2014;98(6):604–611. doi:10.1097/TP.0000000000000262.
   PubMed Web of Science ®Google Scholar
• Qi M, Zheng L, Qi Y, et al. Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70. Pharmacol Res. 2015;100:341–352. doi:10.1016/j.phrs.2015.08.025.
   PubMed Web of Science ®Google Scholar
• Xu T, Zheng L, Xu L, et al. Protective effects of dioscin against alcohol-induced liver injury. Arch Toxicol. 2014;88(3):739–753. doi:10.1007/s00204-013-1148-8.
   PubMed Web of Science ®Google Scholar
• Zhang X, Han X, Yin L, et al. Potent effects of dioscin against liver fibrosis. Sci Rep. 2015;5(1):9713. doi:10.1038/srep09713.
   PubMed Web of Science ®Google Scholar
• Zhang A, Jia Y, Xu Q, et al. Dioscin protects against ANIT-induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats. Toxicol Appl Pharmacol. 2016;305:127–135. doi:10.1016/j.taap.2016.06.019.
   PubMed Web of Science ®Google Scholar
• Liu M, Xu Y, Han X, et al. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-kappaB signaling pathway. Sci Rep. 2016;5(1):18038. doi:10.1038/srep18038.
   Web of Science ®Google Scholar
• Gu L, Tao X, Xu Y, et al. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway. Toxicol Appl Pharmacol. 2016;292:19–29. doi:10.1016/j.taap.2015.12.024.
   PubMed Web of Science ®Google Scholar
• Tao X, Qi Y, Xu L, et al. Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis. Pharmacol Res. 2016;108:90–101. doi:10.1016/j.phrs.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Qu X, Zhai Z, Liu X, et al. Dioscin inhibits osteoclast differentiation and bone resorption though down-regulating the Akt signaling cascades. Biochem Biophys Res Commun. 2014;443(2):658–665. doi:10.1016/j.bbrc.2013.12.029.
   PubMed Web of Science ®Google Scholar
• Guo Y, Xing E, Song H, et al. Therapeutic effect of dioscin on collagen-induced arthritis through reduction of Th1/Th2. Int Immunopharmacol. 2016;39:79–83. doi:10.1016/j.intimp.2016.06.029.
   PubMed Web of Science ®Google Scholar
• Wu S, Xu H, Peng J, et al. Potent anti-inflammatory effect of dioscin mediated by suppression of TNF-alpha-induced VCAM-1, ICAM-1and EL expression via the NF-kappaB pathway. Biochimie. 2015;110:62–72. doi:10.1016/j.biochi.2014.12.022.
   PubMed Web of Science ®Google Scholar
• Yao H, Hu C, Yin L, et al. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway. Int Immunopharmacol. 2016; 36:132–141. doi:10.1016/j.intimp.2016.04.023.
   PubMed Web of Science ®Google Scholar
• Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759–765. doi:10.1038/nm.2736.
   PubMed Web of Science ®Google Scholar
• Lin S, Wu H, Wang C, et al. Regulatory T cells and acute lung injury: cytokines, uncontrolled inflammation, and therapeutic implications. Front Immunol. 2018;9:1545. doi:10.3389/fimmu.2018.01545.
   PubMed Web of Science ®Google Scholar
• Abraham E. Neutrophils and acute lung injury. Crit Care Med. 2003;31(Supplement):S195–S199. doi:10.1097/01.CCM.0000057843.47705.E8.
   PubMed Web of Science ®Google Scholar
• Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2011;17(3-4):293–307. doi:10.2119/molmed.2010.00138.
   PubMed Web of Science ®Google Scholar
• Kayal S, Jais JP, Aguini N, et al. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med. 1998;157(3):776–784. doi:10.1164/ajrccm.157.3.9705034.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest. 2002;109(6):699–705. doi:10.1172/JCI0215277.
   PubMed Web of Science ®Google Scholar
• Ni YF, Jiang T, Cheng QS, et al. Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice. Inflammation. 2012;35(6):1860–1866. doi:10.1007/s10753-012-9507-9.
   PubMed Web of Science ®Google Scholar
• Wright JG, Christman JW. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med. 2003;2(3):211–219. doi:10.1007/BF03256650.
   PubMedGoogle Scholar
• Li Z, Xiao X, Yang M. Asiatic acid inhibits lipopolysaccharide-induced acute lung injury in mice. Inflammation. 2016;39(5):1642–1648. doi:10.1007/s10753-016-0398-z.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373–384. doi:10.1038/ni.1863.
   PubMed Web of Science ®Google Scholar
• Schnare M, Barton GM, Holt AC, et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol. 2001;2(10):947–950. doi:10.1038/ni712.
   PubMed Web of Science ®Google Scholar
• Yao H, Sun Y, Song S, et al. Protective effects of dioscin against lipopolysaccharide-induced acute lung injury through inhibition of oxidative stress and inflammation. Front Pharmacol. 2017;8: 120. doi:10.3389/fphar.2017.00120.
   PubMed Web of Science ®Google Scholar
•  Zeng H, Yang L, Zhang X, et al. Dioscin prevents LPS-induced acute lung injury through inhibiting the TLR4/MyD88 signaling pathway via upregulation of HSP70. Mol Med Rep.2018;17:6752–6758.
   Google Scholar
• Patel VJ, Biswas Roy S, Mehta HJ, et al. Alternative and natural therapies for acute lung injury and acute respiratory distress syndrome. BioMed Res Int. 2018;2018:1–9. doi:10.1155/2018/2476824.
   Web of Science ®Google Scholar
• Yuan Z, Syed MA, Panchal D, et al. Curcumin mediated epigenetic modulation inhibits TREM-1 expression in response to lipopolysaccharide. Int J Biochem Cell Biol. 2012;44(11):2032–2043. doi:10.1016/j.biocel.2012.08.001.
   PubMed Web of Science ®Google Scholar
• Huo M, Chen N, Chi G, et al. Traditional medicine alpinetin inhibits the inflammatory response in Raw 264.7 cells and mouse models. Int Immunopharmacol. 2012;12(1):241–248. doi:10.1016/j.intimp.2011.11.017.
   PubMed Web of Science ®Google Scholar
• Bai G, Yu H, Ni Y, et al. Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice. J Surg Res. 2013;182(2):303–311. doi:10.1016/j.jss.2012.10.039.
   PubMed Web of Science ®Google Scholar
• Qi M, Yin L, Xu L, et al. Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway. Pharmacol Res. 2016;111:509–522. doi:10.1016/j.phrs.2016.07.016.
   PubMed Web of Science ®Google Scholar